Clinical Trials Directory

Trials / Unknown

UnknownNCT05992337

New Biomarkers in the Prediction of Chemotherapy-induced Cardiotoxicity.

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Cardiology Prague · Network
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Early detection and thus rapid therapy of cardiotoxicity related to chemotherapy are essential for restoring cardiovascular function. The complete recovery of the cardiovascular system decreases with time to identify the presence of cardiotoxic damage. The project aims to define new biomarkers for the early detection of cardiotoxicity in patients treated with chemotherapy.

Detailed description

The most effective approach to minimizing the consequences of cardiotoxicity of oncological treatment is its early identification, adjustment of oncological treatment (change of procedure, dose, drugs), and immediate initiation of cardiovascular therapy. However, the current standard for monitoring the cardiovascular system in cancer patients identifies cardiotoxicity only if functional impairment has already occurred, which precludes any chance of effective prevention. The aim of the project is to identify new biomarkers for the early detection of the cardiotoxic effect of chemotherapy in women with breast cancer.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBlood samplingBlood sample collection for mRNA determination
DIAGNOSTIC_TESTEchocardiographyEchocardiography for detection of ventricular dysfunction
DIAGNOSTIC_TESTCardio MRIMRI for early detection of myocardial impairment caused by chemotherapy
DIAGNOSTIC_TEST24-hours monitoring of ECGDiagnostic test for detection of arrhythmias as a consequence of cardiotoxicity
DIAGNOSTIC_TEST24 hours monitoring of BPDiagnostic test for detection of hypertension as a consequence of cardiotoxicity

Timeline

Start date
2021-09-01
Primary completion
2024-11-01
Completion
2025-01-01
First posted
2023-08-15
Last updated
2023-08-16

Locations

2 sites across 1 country: Czechia

Source: ClinicalTrials.gov record NCT05992337. Inclusion in this directory is not an endorsement.